Performance. Defined.

InVitria Blog | Cell Culture and Biotech Manufacturing Insights

Scott Deeter

Scott Deeter
Mr. Deeter is InVitria’s President and CEO and works with InVitria’s customers and partners to help them achieve their cell culture performance, regulatory and quality objectives by implementing the innovative technologies and blood-free cell culture products developed by InVitria’s scientists.
Find me on:

Recent Posts

BIO 2018: The Emergence of Gene & Cell Therapy

Posted By Scott Deeter on 6/11/18 11:10 AM

Last week InVitria attended and celebrated the 25th anniversary of the Biotechnology Industry Organization (BIO) at their annual conference. More than 18,000 delegates over 7,000 companies flew in from around the world and joined InVitria at this event in Boston. A few highlights that emerged from the BIO 2018 conference include: 

Read More

Subscribe to our Blog:

Follow InVitria: